Tam, Friederike I. http://orcid.org/0000-0001-8333-867X
King, Joseph A.
Geisler, Daniel http://orcid.org/0000-0003-2076-5329
Korb, Franziska M.
Sareng, Juliane
Ritschel, Franziska
Steding, Julius
Albertowski, Katja U.
Roessner, Veit
Ehrlich, Stefan http://orcid.org/0000-0003-2132-4445
Article History
Received: 9 February 2017
Accepted: 25 September 2017
First Online: 19 October 2017
Competing Interests
: V.R. has received payment for consulting and writing activities from Lilly, Novartis and Shire Pharmaceuticals; lecture honoraria from Lilly, Novartis, Shire Pharmaceuticals and Medice Pharma; and support for research from Shire and Novartis. He has carried out (and is currently carrying out) clinical trials in cooperation with Novartis, Shire and Otsuka. The other authors declare that they have no competing interests.